Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients.
Kernan NA, Klein E, Mauguen A, Torok-Castanza J, Prockop SE, Scaradavou A, Curran K, Spitzer B, Cancio M, Ruggiero J, Allen J, Harris A, Oved J, O'Reilly RJ, Boelens JJ. Kernan NA, et al. Among authors: curran k. Transplant Cell Ther. 2024 Apr 20:S2666-6367(24)00351-8. doi: 10.1016/j.jtct.2024.04.012. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38643958
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
Kunvarjee B, Bidgoli A, Madan RP, Vidal E, McAvoy D, Hosszu KK, Scaradavou A, Spitzer BG, Curran KJ, Cancio M, Harris AC, O'Reilly RJ, Kung AL, Prockop S, Boelens JJ, Oved JH. Kunvarjee B, et al. Among authors: curran kj. J Allergy Clin Immunol. 2023 Sep;152(3):815-817. doi: 10.1016/j.jaci.2023.05.016. Epub 2023 Jun 26. J Allergy Clin Immunol. 2023. PMID: 37367708 No abstract available.
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.
Tamari R, Scordo M, Kunvarjee BM, Proli A, Lin A, Flynn J, Cho C, Devlin S, Klein E, Boulad F, Cancio MI, Curran KJ, Jakubowski AA, Kernan NA, Kung AL, O'Reilly RJ, Papadopoulos EB, Prockop S, Scaradavou A, Shaffer BC, Shah G, Spitzer B, Gyurkocza B, Giralt SA, Perales MA, Boelens JJ. Tamari R, et al. Blood Adv. 2023 Sep 26;7(18):5225-5233. doi: 10.1182/bloodadvances.2023009708. Blood Adv. 2023. PMID: 37379285 Free PMC article.
Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients.
Troullioud Lucas AG, Boelens JJ, Prockop SE, Curran KJ, Bresters D, Kollen W, Versluys B, Bierings MB, Archer A, Davis E, Klein E, Kernan NA, Lindemans CA, Scaradavou A. Troullioud Lucas AG, et al. Front Oncol. 2023 Aug 15;13:1221782. doi: 10.3389/fonc.2023.1221782. eCollection 2023. Front Oncol. 2023. PMID: 37649924 Free PMC article.
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
Satty AM, Klein E, Mauguen A, Kunvarjee B, Boelens JJ, Cancio M, Curran KJ, Kernan NA, Prockop SE, Scaradavou A, Spitzer B, Tamari R, Ruggiero J, Torok-Castanza J, Mehta PA, O'Reilly RJ, Boulad F. Satty AM, et al. Bone Marrow Transplant. 2024 Jan;59(1):23-33. doi: 10.1038/s41409-023-02113-1. Epub 2023 Sep 29. Bone Marrow Transplant. 2024. PMID: 37773270
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
Lakkaraja M, Mauguen A, Boulad F, Cancio MI, Curran KJ, Harris AC, Kernan NA, Klein E, Kung AL, Oved J, Prockop S, Scaradavou A, Spitzer B, O'Reilly RJ, Boelens JJ. Lakkaraja M, et al. Among authors: curran kj. Cytotherapy. 2024 Apr;26(4):351-359. doi: 10.1016/j.jcyt.2024.01.004. Epub 2024 Feb 12. Cytotherapy. 2024. PMID: 38349310
Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation.
Major-Monfried H, Hosszu K, McAvoy DP, Vallone A, Shukla N, Gillio A, Spitzer B, Kung AL, Cancio M, Curran K, Scaradavou A, Oved JH, O'Reilly RJ, Boelens JJ, Harris AC. Major-Monfried H, et al. Among authors: curran k. Cytotherapy. 2024 May;26(5):466-471. doi: 10.1016/j.jcyt.2024.01.005. Epub 2024 Feb 29. Cytotherapy. 2024. PMID: 38430078
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.
Prockop SE, Hasan A, Doubrovina E, Dahi PB, Rodriguez-Sanchez I, Curry M, Mauguen A, Papanicolaou GA, Su Y, Yao J, Arcila M, Boulad F, Castro-Malaspina H, Cho C, Curran KJ, Giralt S, Kernan NA, Koehne G, Jakubowski A, Papadopoulos E, Perales MA, Politikos I, Price K, Selvakumar A, Sauter CS, Tamari R, Vizconde T, Young JW, O'Reilly RJ. Prockop SE, et al. Among authors: curran kj. J Clin Invest. 2023 May 15;133(10):e165476. doi: 10.1172/JCI165476. J Clin Invest. 2023. PMID: 36951958 Free PMC article.
Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.
Kunvarjee B, Contreras Yametti GP, Blouin AG, Linder GE, Borge PD, Maryamchik E, Budhai A, Gupta GK, Scaradavou A, Spitzer BG, Curran KJ, Oved JH, Harris AC, Sharma A, Boelens JJ, Cancio MI. Kunvarjee B, et al. Among authors: curran kj. Br J Haematol. 2024 Apr;204(4):1540-1544. doi: 10.1111/bjh.19289. Epub 2024 Jan 11. Br J Haematol. 2024. PMID: 38212144 No abstract available.
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia.
Myers RM, Jacoby E, Pulsipher MA, Pasquini MC, Grupp SA, Shah NN, Laetsch TW, Curran KJ, Schultz LM. Myers RM, et al. Transplant Cell Ther. 2023 Oct;29(10):598-607. doi: 10.1016/j.jtct.2023.07.016. Epub 2023 Jul 20. Transplant Cell Ther. 2023. PMID: 37481241 Review.
341 results